Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Emi Ota Machida"'
Autor:
Genevieve Pridham, James G. Herman, Edward Gabrielson, Yu Han, Craig M. Hooker, Emi Ota-Machida, Stephen Ames, Steven Piantadosi, Stephen C. Yang, Malcolm V. Brock, Stephen B. Baylin, Steven A. Belinsky, Sabine C. Glöckner, Kristen Pelosky, Mingzhou Guo
Publikováno v:
The New England journal of medicine, vol 358, iss 11
Brock, MV; Hooker, CM; Ota-Machida, E; Han, Y; Guo, M; Ames, S; et al.(2008). DNA methylation markers and early recurrence in stage I lung cancer. New England Journal of Medicine, 358(11), 1118-1128. doi: 10.1056/NEJMoa0706550. UCLA: Retrieved from: http://www.escholarship.org/uc/item/3nd5k29c
Brock, MV; Hooker, CM; Ota-Machida, E; Han, Y; Guo, M; Ames, S; et al.(2008). DNA methylation markers and early recurrence in stage I lung cancer. New England Journal of Medicine, 358(11), 1118-1128. doi: 10.1056/NEJMoa0706550. UCLA: Retrieved from: http://www.escholarship.org/uc/item/3nd5k29c
Background: Despite optimal and early surgical treatment of non-small-cell lung cancer (NSCLC), many patients die of recurrent NSCLC. We investigated the association between gene methylation and recurrence of the tumor. Methods: Fifty-one patients wi
Autor:
Wei Zhang, Jun Amano, Malcolm V. Brock, Leander Van Neste, Julien D.F. Licchesi, Stephen B. Baylin, Noreli Franco, Alicia Hulbert, Craig M. Hooker, Emi Ota Machida, Kornel E. Schuebel, Mathewos Tessema, Steven A. Belinsky, Sabine C. Glöckner, John Wrangle, James G. Herman, Nita Ahuja, Ludmila Danilova, Hariharan Easwaran
Purpose: Non–small cell lung cancer (NSCLC) is the leading cause of cancer mortality in the world. Novel diagnostic biomarkers may augment both existing NSCLC screening methods as well as molecular diagnostic tests of surgical specimens to more acc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b23167cad5d299ecf0b6fc3d85537882
https://europepmc.org/articles/PMC4019442/
https://europepmc.org/articles/PMC4019442/